Biotech · Public company · La Jolla, CA, US
Zura Bio Ltd
Ticker ZURA · SEC CIK 0001855644
Track this companyFree. Adds Zura Bio Ltd to your Dealase workspace and tells you when its record changes.
Clinical trials22 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availableNo recent cash burn filed
Pipeline3
- TibulizumabPhase 2 · Systemic Sclerosis (SSc)ClinicalTrials.gov · fetched Nov 12, 2026
- Tibulizumab Dose APhase 2 · Hidradenitis Suppurativa (HS)ClinicalTrials.gov · fetched Nov 12, 2026
- Tibulizumab Dose BPhase 2 · Hidradenitis Suppurativa (HS)ClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- Tibulizumab Skin Healing and Inflammation Evaluation for Lasting DefensePHASE2 · ACTIVE_NOT_RECRUITING · started May 16, 2025ClinicalTrials.gov NCT06993610 · fetched Nov 12, 2026
- Tibulizumab Systemic Sclerosis Understanding and Response Evaluation (TibuSURE)PHASE2 · ACTIVE_NOT_RECRUITING · started Feb 6, 2025ClinicalTrials.gov NCT06843239 · fetched Nov 12, 2026
SEC filings12
- 8-K · FORM 8-KSEC EDGAR · filed Nov 9, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Oct 27, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Oct 27, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Aug 17, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Aug 11, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Aug 11, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Jul 1, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Jun 18, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed May 22, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed May 7, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed May 7, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Apr 23, 2026 · fetched Nov 12, 2026